Researchers used gene therapy to convert harmful fatty acids into beneficial ones to help combat childhood obesity.

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for ...

Single-atom editing under mild conditions was achieved for heterocyclics, thanks to a new oxygen-to-nitrogen photocatalyst.

Illumina unveiled its MiSeq i100 Series of sequencing systems: two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus ...

Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility ...

Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our ...

Researchers hope to plan clinical trials of 5-fluorouracil with drugs that would enhance its RNA-damaging effects and kill ...

Findings implied more generally that the effects of dietary restriction on health and lifespan may be partially ...

The company claims to have decoded human cell rejuvenation and identified potential gene targets for therapies that treat ...

Newly launched Judo Bio aims to develop ligand-siRNA conjugates through its Selectively Targeting RNA Into KidnEy (STRIKE) ...

The company reflects on their latest IND approval, the evolution of their end-to-end drug discovery platform, and what’s next ...